Copyright © 2009 Govindan Dayanithi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. D. E. Goll, V. F. Thompson, H. Li, W. Wei, and J. Cong, “The calpain system,” Physiological Reviews, vol. 83, no. 3, pp. 731–801, 2003. View at Scopus
2. D. E. Croall and G. N. DeMartino, “Calcium-activated neutral protease (calpain) system: structure, function, and regulation,” Physiological Reviews, vol. 71, no. 3, pp. 813–847, 1991. View at Scopus
3. E. Carafoli and M. Molinari, “Calpain: a protease in search of a function?” Biochemical and Biophysical Research Communications, vol. 247, no. 2, pp. 193–203, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
4. I. Richard, O. Broux, V. Allamand, et al., “Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A,” Cell, vol. 81, no. 1, pp. 27–40, 1995. View at Scopus
5. S. Baghdiguian, M. Martin, I. Richard, et al., “Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the I$\kappa$B $\alpha$/NF-$\kappa$B pathway in limb-girdle muscular dystrophy type 2A,” Nature Medicine, vol. 5, no. 5, pp. 503–511, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
6. I. Richard, C. Roudaut, S. Marchand, et al., “Loss of calpain 3 proteolytic activity leads to muscular dystrophy and to apoptosis-associated I$\kappa$B$\alpha$/nuclear factor $\kappa$B pathway perturbation in mice,” Journal of Cell Biology, vol. 151, no. 7, pp. 1583–1590, 2000. View at Publisher · View at Google Scholar · View at Scopus
7. V. Shoshan-Barmatz, S. Weil, H. Meyer, M. Varsanyi, and L. M. G. Heilmeyer, “Endogenous, ${\text{Ca}}^{2+}$-dependent cysteine-protease cleaves specifically the ryanodine receptor/${\text{Ca}}^{2+}$ release channel in skeletal muscle,” Journal of Membrane Biology, vol. 142, no. 3, pp. 281–288, 1994. View at Scopus
8. J. Alterio, Y. Courtois, J. Robelin, D. Bechet, and I. Martelly, “Acidic and basic fibroblasts growth factor mRNAs are expressed by skeletal muscle satellite cells,” Biochemical and Biophysical Research Communications, vol. 166, no. 3, pp. 1205–1212, 1990. View at Publisher · View at Google Scholar · View at Scopus
9. S. J. Martin, M. A. P. Audrain, F. Oksman, et al., “Antineutrophil cytoplasmic antibodies (ANCA) in chronic graft-versus-host disease after allogeneic bone marrow transplantation,” Bone Marrow Transplantation, vol. 20, no. 1, pp. 45–48, 1997. View at Scopus
10. R. C. Lambert, G. Dayanithi, F. C. Moos, and Ph. Richard, “A rise in the intracellular ${\text{Ca}}^{2+}$ concentration of isolated rat supraoptic cells in response to oxytocin,” Journal of Physiology, vol. 478, no. 2, pp. 275–287, 1994. View at Scopus
11. G. Dayanithi, H. Widmer, and Ph. Richard, “Vasopressin-induced intracellular ${\text{Ca}}^{2+}$ increase in isolated rat supraoptic cells,” Journal of Physiology, vol. 490, no. 3, pp. 713–727, 1996. View at Scopus
12. F. Jamen, G. Alonso, I. Shibuya, et al., “Impaired somatodendritic responses to pituitary adenylate cyclase-activating polypeptide (PACAP) of supraoptic neurones in PACAP type I-receptor deficient mice,” Journal of Neuroendocrinology, vol. 15, no. 9, pp. 871–881, 2003. View at Publisher · View at Google Scholar · View at Scopus
13. G. Grynkiewicz, M. Poenie, and R. Y. Tsien, “A new generation of ${\text{Ca}}^{2+}$ indicators with greatly improved fluorescence properties,” Journal of Biological Chemistry, vol. 260, no. 6, pp. 3440–3450, 1985. View at Scopus
14. I. Marty, M. Robert, M. Villaz, et al., “Biochemical evidence for a complex involving dihydropyridine receptor and ryanodine receptor in triad junctions of skeletal muscle,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 6, pp. 2270–2274, 1994. View at Scopus
15. S. Shevchenko, W. Feng, M. Varsanyi, and V. Shoshan-Barmatz, “Identification, characterization and partial purification of a thiol-protease which cleaves specifically the skeletal muscle ryanodine receptor/${\text{Ca}}^{2+}$ release channel,” Journal of Membrane Biology, vol. 161, no. 1, pp. 33–43, 1998. View at Publisher · View at Google Scholar · View at Scopus
16. B. Benayoun, S. Baghdiguian, A. Lajmanovich, et al., “NF-$\kappa$B-dependent expression of the antiapoptotic factor c-FLIP is regulated by calpain 3, the protein involved in limb-girdle muscular dystrophy type 2A,” FASEB Journal, vol. 22, no. 5, pp. 1521–1529, 2008. View at Publisher · View at Google Scholar · View at PubMed
17. R. Wang, L. Zhang, J. Bolstad, et al., “Residue Gln4863 within a predicted transmembrane sequence of the ${\text{Ca}}^{2+}$ release channel (ryanodine receptor) is critical for ryanodine interaction,” Journal of Biological Chemistry, vol. 278, no. 51, pp. 51557–51565, 2003. View at Publisher · View at Google Scholar · View at PubMed
18. J. D. Fessenden, L. Chen, Y. Wang, et al., “Ryanodine receptor point mutant E4032A reveals an allosteric interaction with ryanodine,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 5, pp. 2865–2870, 2001. View at Publisher · View at Google Scholar · View at PubMed
19. T. Yang, P. D. Allen, I. N. Pessah, and J. R. Lopez, “Enhanced excitation-coupled calcium entry in myotubes is associated with expression of RyR1 malignant hyperthermia mutations,” Journal of Biological Chemistry, vol. 282, no. 52, pp. 37471–37478, 2007. View at Publisher · View at Google Scholar · View at PubMed
20. F. Naro, V. De Arcangelis, D. Coletti, et al., “Increase in cytosolic ${\text{Ca}}^{2+}$ induced by elevation of extracellular ${\text{Ca}}^{2+}$ in skeletal myogenic cells,” American Journal of Physiology, vol. 284, no. 4, pp. C969–C976, 2003.
21. N. Khandoudi, J. Percevault-Albadine, and A. Bril, “Consequences of the inhibition of the sarcoplasmic reticulum calcium ATPase on cardiac function and coronary flow in rabbit isolated perfused heart: role of calcium and nitric oxide,” Journal of Molecular and Cellular Cardiology, vol. 30, no. 10, pp. 1967–1977, 1998. View at Publisher · View at Google Scholar · View at PubMed
22. E. B. Okon, A. Golbabaie, and C. van Breemen, “In the presence of L-NAME SERCA blockade induces endothelium-dependent contraction of mouse aorta through activation of smooth muscle prostaglandin H2/thromboxane A2 receptors,” British Journal of Pharmacology, vol. 137, no. 4, pp. 545–553, 2002. View at Publisher · View at Google Scholar · View at PubMed
23. R. I. Jabr, H. Toland, C. H. Gelband, X. X. Wang, and J. R. Hume, “Prominent role of intracellular ${\text{Ca}}^{2+}$ release in hypoxic vasoconstriction of canine pulmonary artery,” British Journal of Pharmacology, vol. 122, no. 1, pp. 21–30, 1997. View at Publisher · View at Google Scholar · View at PubMed
24. P. R. Turner, T. Westwood, C. M. Regen, and R. A. Steinhardt, “Increased protein degradation results from elevated free calcium levels found in muscle from mdx mice,” Nature, vol. 335, no. 6192, pp. 735–738, 1988.
25. F. Salamino, B. Sparatore, E. Melloni, et al., “The plasma membrane calcium pump is the preferred calpain substrate within the erythrocyte,” Cell Calcium, vol. 15, no. 1, pp. 28–35, 1994. View at Publisher · View at Google Scholar
26. G. Dayanithi, I. Mechaly, C. Viero, et al., “Intracellular ${\text{Ca}}^{2+}$ regulation in rat motoneurons during development,” Cell Calcium, vol. 39, no. 3, pp. 237–246, 2006. View at Publisher · View at Google Scholar · View at PubMed
27. D. M. Bers, Excitation-Contraction Coupling and Cardiac Contractile Force, Kluwer Academic Publishers, Dordrecht, The Netherlands, 2001.
28. E. Verburg, R. M. Murphy, I. Richard, and G. D. Lamb, “Involvement of calpains in ${\text{Ca}}^{2+}$-induced disruption of excitation-contraction coupling in mammalian skeletal muscle fibers,” American Journal of Physiology, vol. 296, no. 5, pp. C1115–C1122, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus